(Q39565319)

13 September 2017

title

New developments on the mechanisms of action of antineoplastic drugs (English)

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

16 April 2022

author name string

R. C. Donehower

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A90325

16 April 2022

C. E. Myers

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A90325

16 April 2022

B. A. Chabner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A90325

16 April 2022

language of work or name

English

0 references

publication date

1 July 1979

1 reference

13 September 2017

2 July 1979

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=90325

full work available at URL

16 April 2022

https://api.elsevier.com/content/article/PII:0024320579904831?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

https://api.elsevier.com/content/article/PII:0024320579904831?httpAccept=text/plain

16 April 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

16 April 2022

1 reference

13 September 2017

volume

25

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

1-14

1 reference

Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin

13 September 2017

cites work

3

77

797

Goodman

1977

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

16 April 2022

Molecular Pharmacology

4

13

901

Bachur

1977

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Adriamycin stimulated superoxide formation in submitochondrial particles

16 April 2022

5

19

265

Thayer

1977

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Bioactivation as a model for drug design bioreductive alkylation

16 April 2022

6

197

527

Moore

1977

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Oxygen-dependent microbial killing by phagocytes (first of two parts).

16 April 2022

11

298

659

Babior

1978

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents

16 April 2022

13

76

705

Lown

0 references

Chemicals, drugs, and lipid peroxidation

16

16

125

Plau

1976

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Effect of dietary vitamin E on expiration of pentane and ethane by the rat

16 April 2022

17

12

109

Dillard

1976

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

DNA-malonaldehyde reaction: formation of fluorescent products

16 April 2022

18

48

921

Reiss

1972

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response

16 April 2022

19

197

165

Myers

1977

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Superoxide dismutase and glutathione peroxidase activities in tumors

16 April 2022

21

78

41

Peskin

1977

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Mechanism of action of bleomycin. Studies with the growing culture of bacterial and tumor cells

16 April 2022

22

21

379

Suzuki

1968

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Effects of Reducing and Oxidizing Agents on the Action of Bleomycin1

16 April 2022

23

77

745

Onishi

1975

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Properties and products of the degradation of DNA by bleomycin and iron(II)

16 April 2022

25

17

2746

Sausville

1978

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Bleomycin-DNA interactions: fluorescence and proton magnetic resonance studies

16 April 2022

26

16

3641

Chien

1977

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Effect of chelating agents and metal ions on the degradation of DNA by bleomycin

16 April 2022

27

17

2740

Sausville

1978

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

The combined effects of bleomycin and sulfhydryl compounds on the thermal denaturation of DNA

16 April 2022

28

179

165

Nagai

1969

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

16 April 2022

29

36

1138

Byfield

1976

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

16 April 2022

30

144

614

Matsuzawa

1972

0 references

Pulmonary complications after bleomycin, irradiation and surgery for esophageal cancer

31

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancer

17 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Reactivation of dihydrofolate reductase inhibited by methotrexate or aminopterin

17 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Preliminary Model for Methotrexate Pharmacokinetics

17 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Pharmacokinetics of methotrexate

17 November 2022

47

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate

17 November 2022

52

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

17 November 2022

Cancer Treatment Reports

53

62

381

Watson

1978

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

The characteristics of the membrane transport of amethopterin and the naturally occurring folates

17 November 2022

60

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate.

17 November 2022

65

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Factors affecting substrate binding in Lactobacillus casei thymidylate synthetase as studied by equilibrium dialysis

17 November 2022

66

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansion

17 November 2022

72

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Combination chemotherapy: The interaction of methotrexate and 5-fluorouracil

17 November 2022

73

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Factors determining cell sensitivity to methotrexate: Studies of folate and deoxyribonucleoside triphosphate pools in five mammalian cell lines

17 November 2022

76

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Enzyme pattern directed chemotherapy. The effects of combinations of methotrexate, 5-fluorodeoxyuridine and thymidine on rat hepatoma cells in vitro

17 November 2022

77

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

Adjuvant postoperative chemotherapy with 5-fluorouracil and methotrexate: Effect of schedule of administration on metastasis of 13762 mammary adenocarcinoma

17 November 2022

83

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90483-1

17 November 2022

Identifiers

1 reference

13 September 2017

1 reference